| α-Syn | Alpha-synuclein |
| AD | Alzheimer’s disease |
| Aβ | Beta-amyloid |
| BBB | Blood–brain barrier |
| CD | Cluster of differentiation 14 |
| CNS | Central nervous system |
| COX-2 | Cyclooxygenase-2 |
| CRP | C-reactive protein |
| CT51 | Coumarin-tris hybrid |
| DHC12 | 7,8-dihydroxycoumarin-12 |
| Hgb | Haemoglobin |
| IFNγ | Interferon-gamma |
| IL | Interleukin |
| iNOS | Inducible nitric oxide synthase |
| LB | Lewy body |
| LPS | Lipopolysaccharide |
| LTA | Lipoteichoic acid |
| MRC | Medical Research Council of South Africa |
| mRNA | Messenger ribonucleic acid |
| MOA | Monoamine oxidase |
| NADPH | Nicotinamide adenine dinucleotide phosphate reduced |
| NF-кB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| PARK | Parkinson’s disease genes |
| PD | Parkinson’s disease |
| RANTES | Regulated upon activation, normal T cell expressed and presumably secreted |
| REM | Rapid eye movement |
| Rgp | Gingipain |
| ROS | Reactive oxygen species |
| SAA | Serum amyloid A |
| SNc | Substantia nigra pars compacta |
| SUMO | Small ubiquitin-like modifier |
| TEM | Transmission electron microscope |
| TLR | Toll-like receptor |
| TNF-α | Tumour necrosis factor-alpha |
| TFN | Transferrin |